Citation: J. Grevel et al., PK PD ANALYSIS OF INTRAVENOUS FENOLDOPAM IN HYPERTENSIVE EMERGENCIES/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 82-82
Citation: J. Grevel et al., PK PD ANALYSIS OF INTRAVENOUS FENOLDOPAM IN HYPERTENSIVE PATIENTS/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 83-83
Authors:
ELTAHTAWY A
GREVEL J
VENITZ J
KARKOWSKY A
PAREKH A
TAYLOR AA
Citation: A. Eltahtawy et al., DUAL EFFECT PK PD MODELING OF INTRAVENOUS FENOLDOPAM IN MODERATE HYPERTENSIVE PATIENTS/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 102-102
Authors:
MUELLER EA
KOVARIK JM
VANBREE JB
TETZLOFF W
GREVEL J
KUTZ K
Citation: Ea. Mueller et al., IMPROVED DOSE LINEARITY OF CYCLOSPORINE PHARMACOKINETICS FROM A MICROEMULSION FORMULATION, Pharmaceutical research, 11(2), 1994, pp. 301-304
Authors:
MUELLER EA
KOVARIK JM
VANBREE JB
GREVEL J
LUCKER PW
KUTZ K
Citation: Ea. Mueller et al., INFLUENCE OF A FAT-RICH MEAL ON THE PHARMACOKINETICS OF A NEW ORAL FORMULATION OF CYCLOSPORINE IN A CROSSOVER COMPARISON WITH THE MARKET FORMULATIONS, Pharmaceutical research, 11(1), 1994, pp. 151-155
Authors:
SERINO F
CITTERIO F
POZZETTO U
GREVEL J
CASTAGNETO M
Citation: F. Serino et al., ABBREVIATED 3-POINT KINETIC PROFILE IN THE 12-HOUR AREA-UNDER-THE-CURVE FOR PHARMACOKINETIC MONITORING OF CYCLOSPORINE, Transplantation proceedings, 26(5), 1994, pp. 2807-2808
Authors:
SERINO F
GREVEL J
NAPOLI KL
KAHAN BD
STROBEL HW
Citation: F. Serino et al., OXYGEN RADICAL FORMATION BY THE CYTOCHROME-P450 SYSTEM AS A CELLULAR MECHANISM FOR CYCLOSPORINE TOXICITY, Transplantation proceedings, 26(5), 1994, pp. 2916-2917
Authors:
SERINO F
GREVEL J
NAPOLI KL
KAHAN BD
STROBEL HW
Citation: F. Serino et al., GENERATION OF OXYGEN-FREE RADICALS DURING THE METABOLISM OF CYCLOSPORINE-A - A CAUSE-EFFECT RELATIONSHIP WITH METABOLISM INHIBITION, Molecular and cellular biochemistry, 122(2), 1993, pp. 101-112
Citation: J. Grevel, AREA-UNDER-THE-CURVE VERSUS TROUGH LEVEL MONITORING OF CYCLOSPORINE CONCENTRATION - CRITICAL-ASSESSMENT OF DOSAGE ADJUSTMENT PRACTICES AND MEASUREMENT OF CLINICAL OUTCOME, Therapeutic drug monitoring, 15(6), 1993, pp. 488-491
Citation: Ss. Ahmed et al., ADRENOCHROME REACTION IMPLICATES OXYGEN RADICALS IN METABOLISM OF CYCLOSPORINE-A AND FK-506 IN RAT AND HUMAN LIVER-MICROSOMES, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1047-1054
Citation: J. Grevel et al., MICHAELIS-MENTEN KINETICS DETERMINE CYCLOSPORINE STEADY-STATE CONCENTRATIONS - A POPULATION ANALYSIS IN KIDNEY-TRANSPLANT PATIENTS, Clinical pharmacology and therapeutics, 53(6), 1993, pp. 651-660